All Programs are accredited by Ministry of Education, UAE. MBBS and BDS Programs are listed in the World Directory of Medical Schools (WDOMS)

Dr. Sirajunisa Talath

Associate Professor

Educational Qualification:
  • Ph. D. (Pharmaceutical Chemistry) Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (August 2007)
  • M. Pharm. (Pharmaceutical Chemistry) Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore, India (March 2002)
  • Bachelor of Pharmacy Gulbarga University, Gulbarga, India, (July 1997)
Professional Career:
  • Associate Professor, Department of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE (November 2017-Present)
  • Assistant Professor, Department of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE (October 2009-October 2017)
  • Associate Professor, Department of Pharmaceutical Chemistry, RMES’s College of Pharmacy, Gulbarga, Karnataka, India (September 2007-October 2009)
  • Assistant Professor, Department of Pharmaceutical Chemistry at NGSM Institute of Pharmaceutical Sciences, Mangalore, Karnataka, India (October, 2005 – August 2007)
  • Lecturer in Pharmaceutical Chemistry at Luqman College of Pharmacy, Gulbarga-2, Karnataka. (November 1997-January 2000)
Achievements/ Interests/Publications/Awards:

Research: 13

Review: 01

Patents: 02

Patents:

  • Bhoomendra A. Bhongade, Sirajunisa Talath. Indian Patent Application (2015)
  • Sirajunisa Talath and Andanappa K. Gadad “Substituted 2-Anilinonicotinic acids and their use in inflammatory condition”, Indian Patent Application No 1114/CHE/2004 (Published 27th Oct 2006).

Research articles:

  • Sirajunisa Talath and Sunil Dhaneshwar. Validated Stability-Indicating RP-HPLC Method for the Determination of Salicylic Acid. American Journal of PharmTech Research 2017: 7(4), 231-249.
  • Sirajunisa Talath and Sunil Dhaneshwar, A RP-HPLC Method Development and Validation of a Stability-Indicating Studies for the Analysis of Drosperinone a Pharmaceutical Product. Indo American Journal of Pharm. Research, 2017:7(01) 7401-10.
  • Bhoomendra A. Bhongade, Sirajunisa Talath, Ravikiran A. Gadad, Andanappa K. Gadad. Biological activities of imidazo[2,1-b][1,3,4]-thiadiazole derivatives: A review Journal of Saudi Chemical Society (2016) 20, S463–S475
  • Bhoomendra Bhongade, Sirajunisa Talath and Sunil Dhaneshwar, A Validated Method for the Quantitation of Ciprofloxacin Hydrochloride Using Diffuse Reflectance Infrared Fourier Transform Spectroscopy. International Journal of Spectroscopy Vol 2014, Article ID 294612, http://dx.doi.org/10.1155/2014/294612.
  • Bhoomendra Bhongade and Sirajunisa Talath. Synthesis and antibacterial evaluation of some new N-(3-Chloro-4-substitutedphenyl) guanidines. Indo American Journal of Pharm Research.2013:3(12) 1293-97

Research interests:

  • Prodrug /intermediate synthesis of NSAIDs
  • Synthesis of small molecule as antimicrobial and anticancer agents
  • Method Development and validation of HPLC method for the quantification of pharmaceuticals/herbal extracts
Conferences/Workshops:

Conference Presentations: 20

Professional Development Programme attended: (34)

  • Workshop on Setting the standard: developing tools to guide the profession 24th DUPHAT; Dubai (February 28, 2019)
  • Workshop on Drug discovery: use of high-throughput screening to identify a new small molecule for treatment of Ewing’s sarcoma; 24th DUPHAT; Dubai (February 27, 2019)
  • Symposium on Medical Education” titled “Challenges in Health Professions Education for 21st Century” at RAK Medical & Health Sciences University, Ras Al Khaimah, UAE. (October 29, 2018)
  • Dr. Sirajunisa Talath and Dr. Sunil Dhaneshwar, Stability Indicating HPLC Method for the Determination of Drosperinone. At 66th Indian Pharmaceutical Congress. January 23-25 2015. Held at HITEX Exhibition Centre, Hyderabad, India.